Overview
- 4 inspections across 4 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-09-05.
At a glance
Inspections
4
Sites
4
Observations
4
Career since
Apr 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Wellstat Therapeutics Inc. | 5 Sep 2019 | Human Drugs | |
| Mikart, LLC | 23 Aug 2018 | Human Drugs | |
| GE Healthcare, Inc. | 25 Jul 2014 | Human Drugs | View 483 → |
| Azur Pharma, Inc. | 1 Apr 2011 |
Sites inspected
Wellstat Therapeutics Inc.Rockville, United States1 insp.
Mikart, LLCAtlanta, United States1 insp.
GE Healthcare, Inc.Princeton, United States1 insp.
Azur Pharma, Inc.Philadelphia, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Robin R Waller1 shared
John Dan1 shared
Vanessa E Coulter1 shared
Russell J Glapion1 shared
Mike M Rashti1 shared
Kendra A Biddick1 shared
Full investigator report
Get the verbatim findings behind Marcia Gelber's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site